Health
Study reveals longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels – Oneindia
‘Our study shows the value of studying both antibody and T cell responses following SARS-CoV-2 vaccine, particularly to understand…
London, Jul 24: A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities…
Continue Reading
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News17 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business20 hours agoThese ASX 200 shares could rise 55% to 65%
-
Noosa News22 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice